Journal of Urgent Care Medicine

FDA Advises to Stop Administering Sterile Products from Medaus

The Food and Drug Administration is asking healthcare professionals to stop administering drug products intended to be sterile that were made by Medaus Inc. due to a lack of sterility assurance. Providers in all settings, including urgent care, are urged to check their supplies and quarantine any “sterile” products from Medaus. Some of the drugs (eg, injectable nutritional products) are more likely to be found in urgent care centers than others, such as injectable hormone …

FDA Panel Calls for Mandatory Opioid Training

Physicians who prescribe opioid pain medications would have to undergo a higher level of specific training under a guidance recommended by a Food and Drug Administration advisory panel. In response to a perceived epidemic of opioid addiction and related deaths, the panel voted unanimously to advice requiring more education about the drugs’ risks. The panel’s vote was unanimous, but not binding—though the FDA does often follow recommendations made by its outside expert panels.